BRESSLER, N. M., M. VEITH, Jan HAMOUZ, Jan ERNEST, D. ZALEWSKI, Jan STUDNICKA, A. VAJAS, A. PAPP, G. VOGT, J. LUU,
Veronika MATUŠKOVÁ, Y. H. YOON, T. PREGUN, T. KIM, D. SHIN, I. OH, H. JEONG, M. Y. KIM and S. J. WOO. Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes.
The British journal of ophthalmology : incorporating the Royal London ophthalmic hospital reports, the Ophthalmic review and the Ophthalmoscope. London: British Journal of Ophthalmology, 2023, vol. 107, No 3, p. 384-391. ISSN 0007-1161. Available from: https://dx.doi.org/10.1136/bjophthalmol-2021-319637.